RSS-Feed abonnieren

DOI: 10.1055/s-0043-1769492
Case Report with a Review of Literature: Pancoast Syndrome—A Rare Presentation of Metastatic Hepatocellular Carcinoma

Abstract
Superior sulcus tumors, also known as Pancoast tumors, present in a distinctive way with Horner's syndrome (ptosis, miosis, and anhidrosis), hand weakness brought on by the atrophy of the intrinsic hand muscles, and excruciating pain along the medial aspect of the arm. (1) Primary lung cancers constitute a majority of Pancoast tumors, but Pancoast syndrome can be multifactorial. (2) Here, we present a case of 62-year-old male who presented with right shoulder pain and weakness for 2 months. Clinically, he had a supraclavicular mass with atrophy of the intrinsic muscles of the hand and sensory-motor weakness. Computed tomography showed a mass lesion in the supraclavicular fossa with the erosion of the T1 vertebra and first rib, mimicking carcinoma right upper lobe. However, the biopsy from the mass was suggestive of metastasis from hepatocellular carcinoma (HCC). Our case report identifies HCC as a rare differential for Pancoast syndrome and highlights the unique metastatic presentation.
Keywords
hepatocellular carcinoma - Pancoast tumor - Pancoast syndrome - metastasis - hepatoid adenocarcinomaPatient Consent
The authors certify that written informed consent was obtained in an appropriate format informing the patient that clinical information and images will be reported in the journal. The patient understands that his name and initials will not be published, and efforts will be made to deidentify any personal identity or information. However, anonymity cannot be guaranteed.
Publikationsverlauf
Artikel online veröffentlicht:
16. Juni 2023
© 2023. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/)
Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India
-
References
- 1 Foroulis CN, Zarogoulidis P, Darwiche K. et al. Superior sulcus (Pancoast) tumors: current evidence on diagnosis and radical treatment. J Thorac Dis 2013; 5 Suppl 4 (Suppl. 04) S342-S358
- 2 Panagopoulos N, Leivaditis V, Koletsis E. et al. Pancoast tumors: characteristics and preoperative assessment. J Thorac Dis 2014; 6 Suppl 1 (Suppl. 01) S108-S115
- 3 Hung JJ, Lin SC, Hsu WH. Pancoast syndrome caused by metastasis to the superior mediastinum of hepatocellular carcinoma. Thorac Cardiovasc Surg 2007; 55 (07) 463-465
- 4 Pancoast HK. Superior pulmonary sulcus tumor: tumor characterized by pain, Horner's syndrome, destruction of bone and atrophy of hand muscles Chairman's address. J Am Med Assoc 1932; 99 (17) 1391-1396
- 5 Lai CL, Lam KC, Wong KP, Wu PC, Todd D. Clinical features of hepatocellular carcinoma: review of 211 patients in Hong Kong. Cancer 1981; 47 (11) 2746-2755
- 6 Primack A, Vogel CL, Kyalwazi SK, Ziegler JL, Simon R, Anthony PP. A staging system for hepatocellular carcinoma: prognostic factors in Ugandan patients. Cancer 1975; 35 (05) 1357-1364
- 7 Llovet JM, Ricci S, Mazzaferro V. et al; SHARP Investigators Study Group. Sorafenib in advanced hepatocellular carcinoma. N Engl J Med 2008; 359 (04) 378-390
- 8 Finn RS, Qin S, Ikeda M. et al; IMbrave150 Investigators. Atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma. N Engl J Med 2020; 382 (20) 1894-1905
- 9 Okuda K, Ohtsuki T, Obata H. et al. Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients. Cancer 1985; 56 (04) 918-928
- 10 Schlageter M, Quagliata L, Matter M, Perrina V, Tornillo L, Terracciano L. Clinicopathological features and metastatic pattern of hepatocellular carcinoma: an autopsy study of 398 patients. Pathobiology 2016; 83 (06) 301-307
- 11 Katyal S, Oliver III JH, Peterson MS, Ferris JV, Carr BS, Baron RL. Extrahepatic metastases of hepatocellular carcinoma. Radiology 2000; 216 (03) 698-703
- 12 Wu W, He X, Andayani D. et al. Pattern of distant extrahepatic metastases in primary liver cancer: a SEER based study. J Cancer 2017; 8 (12) 2312-2318
- 13 Velloni F, Ramalho M, AlObaidy M, Matos AP, Altun E, Semelka RC. Bone metastases of hepatocellular carcinoma: appearance on MRI using a standard abdominal protocol. AJR Am J Roentgenol 2016; 206 (05) 1003-1012
- 14 Doval DC, Bhatia K, Vaid AK. et al. Spinal cord compression secondary to bone metastases from hepatocellular carcinoma. World J Gastroenterol 2006; 12 (32) 5247-5252
- 15 Kantharia B, Nizam R, Friedman H, Vardan S. Case report: spinal cord compression due to metastatic hepatocellular carcinoma. Am J Med Sci 1993; 306 (04) 233-235
- 16 Omura K, Kawaura Y, Murakami N, Morita K, Iwa T, Sasaki S. [A hepatocellular carcinoma revealed by paraplegia caused by a vertebral metastasis]. Gan No Rinsho 1989; 35 (12) 1448-1452
- 17 Forner A, Vilana R, Ayuso C. et al. Diagnosis of hepatic nodules 20 mm or smaller in cirrhosis: prospective validation of the noninvasive diagnostic criteria for hepatocellular carcinoma. Hepatology 2008; 47 (01) 97-104
- 18 Cong WM, Bu H, Chen J. et al; Guideline Committee. Practice guidelines for the pathological diagnosis of primary liver cancer: 2015 update. World J Gastroenterol 2016; 22 (42) 9279-9287
- 19 Histopathology of hepatocellular carcinoma - when and what [Internet]. [cited April 6, 2022]. Accessed May 6, 2023 at: https://hrjournal.net/article/view/4511
- 20 Nguyen T, Phillips D, Jain D. et al. Comparison of 5 immunohistochemical markers of hepatocellular differentiation for the diagnosis of hepatocellular carcinoma. Arch Pathol Lab Med 2015; 139 (08) 1028-1034
- 21 Hou Z, Xie J, Zhang L, Dai G, Chen Y, He L. Hepatoid adenocarcinoma of the lung: a systematic review of the literature from 1981 to 2020. Front Oncol 2021; 11: 702216 https://www.frontiersin.org/articles/10.3389/fonc.2021.702216 cited December 24, 2022
- 22 Hepatoid adenocarcinoma of the lung: An analysis of the Surveillance, Epidemiology, and End Results (SEER) database [Internet]. [cited December 24, 2022]. Accessed May 6, 2023 at: https://www.degruyter.com/document/doi/10.1515/med-2021-0215/html
- 23 Fakhruddin N, Bahmad HF, Aridi T. et al. Hepatoid adenocarcinoma of the stomach: a challenging diagnostic and therapeutic disease through a case report and review of the literature. Front Med (Lausanne) 2017; 4: 164 https://www.frontiersin.org/articles/10.3389/fmed.2017.00164 cited December 24, 2022
- 24 Su JS, Chen YT, Wang RC, Wu CY, Lee SW, Lee TY. Clinicopathological characteristics in the differential diagnosis of hepatoid adenocarcinoma: a literature review. World J Gastroenterol 2013; 19 (03) 321-327